Nov 6, 2018 04:01PM
Nov 6, 2018 04:01PM
Oct 12, 2018 09:20AM
Oct 11, 2018 05:42PM
Oct 11, 2018 04:03PM
Oct 11, 2018 04:01PM
Oct 11, 2018 04:01PM Immune Design Announces Program Updates & Portfolio Prioritization for G100 and CMB305
Aug 3, 2018 07:35AM
Aug 1, 2018 04:01PM
Aug 1, 2018 04:01PM
May 24, 2018 08:05AM
May 24, 2018 08:00AM
May 24, 2018 08:00AM
May 2, 2018 04:01PM Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 2, 2018 04:01PM
Mar 14, 2018 04:01PM
Mar 14, 2018 04:01PM
Mar 12, 2018 08:04AM
Mar 12, 2018 08:00AM
Mar 12, 2018 08:00AM
Dec 10, 2017 09:00AM Combination of G100 with KEYTRUDA (pembrolizumab) Triggers Robust Systemic Responses in Follicular NHL Patients
Dec 10, 2017 09:00AM
Nov 1, 2017 04:02PM
Oct 19, 2017 04:37PM
Oct 19, 2017 04:05PM
Oct 17, 2017 09:24AM
Oct 16, 2017 05:58PM
Oct 16, 2017 04:22PM Immune Design (IMDZ) Reports Positive FDA Feedback on Phase 3 Clinical Trial Design for CMB305 in Synovial Sarcoma Patients
Oct 16, 2017 04:15PM
Sep 8, 2017 05:45AM
Sep 8, 2017 04:00AM
Aug 31, 2017 05:51AM
Aug 30, 2017 06:42PM
Aug 2, 2017 04:02PM
Jun 5, 2017 08:00AM Immune Design Updates Positive Data from Lead Cancer Immunotherapy Programs at ASCO Annual Meeting
May 17, 2017 04:35PM
May 17, 2017 04:30PM
Feb 22, 2017 08:12AM
Feb 22, 2017 08:00AM

322,224 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All